About Merck
Merck is a company based in Cambridge (United States) founded in 2015 was acquired by Merck Sharp & Dohme in January 2024. It operates as a Direct-to-Consumer (D2C), and Professional Services. Merck has raised $130 million across 5 funding rounds from investors including UBS, New Leaf Venture Partners and Citadel. The company has 93 employees as of December 31, 2021. Merck offers products and services including Medicines and Vaccines and Animal Health Products. Merck operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Cambridge, United States
- Employees 93 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Merck & Co., Inc.
-
Annual Revenue
$00as on Apr 07, 2023
-
Net Profit
-
EBITDA
-
Total Equity Funding
$130 M (USD)
in 5 rounds
-
Latest Funding Round
$100.16 M (USD), Post-IPO
Oct 23, 2023
-
Investors
UBS
& 19 more
-
Employee Count
93
as on Dec 31, 2021
-
Acquired by
Merck Sharp & Dohme
(Jan 08, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Merck
Merck offers a comprehensive portfolio of products and services, including Medicines and Vaccines and Animal Health Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medicines and vaccines are developed for various diseases.
Products for animal health are offered globally.
Unlock access to complete
Funding Insights of Merck
Merck has successfully raised a total of $130M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $100.16 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $100.2M
-
First Round
First Round
(31 Mar 2016)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Post-IPO - Merck | Valuation |
investors |
|
| Mar, 2023 | Amount | Post-IPO - Merck | Valuation |
investors |
|
| Nov, 2018 | Amount | Series C - Merck | Valuation | Orbimed , Arix Bioscience |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Merck
Merck has secured backing from 20 investors, including venture fund and institutional investors. Prominent investors backing the company include UBS, New Leaf Venture Partners and Citadel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital is provided to healthcare startups by Commodore Capital.
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life sciences are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Merck
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Merck
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Merck Comparisons
Competitors of Merck
Merck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Merck
Frequently Asked Questions about Merck
When was Merck founded?
Merck was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Merck located?
Merck is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Merck a funded company?
Merck is a funded company, having raised a total of $130M across 5 funding rounds to date. The company's 1st funding round was a Series C of $70M, raised on Mar 31, 2016.
How many employees does Merck have?
As of Dec 31, 2021, the latest employee count at Merck is 93.
What does Merck do?
Merck is established as a premier biopharmaceutical company focused on research and development. The company is engaged in creating innovative medicines and vaccines across various therapeutic areas including oncology, infectious diseases, and cardio-metabolic disorders. Solutions are developed through advanced data science, artificial intelligence, and sustainable science practices. Operations are conducted with a commitment to sustainability, aiming to benefit global communities. The companys efforts are directed towards addressing critical health challenges and improving patient outcomes worldwide.
Who are the top competitors of Merck?
Merck's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Merck offer?
Merck offers Medicines and Vaccines and Animal Health Products.
Who are Merck's investors?
Merck has 20 investors. Key investors include UBS, New Leaf Venture Partners, Citadel, Orbimed, and RA Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.